Quest Diagnostics (DGX) news
Recent news
Quest Diagnostics - to launch new AD-Detect multi-biomarker lab test nationwide at month-end
AInvest Wire · 7d agoQuest Diagnostics - to incorporate Roche PTAU217 test in AD-Detect panels in 2027
AInvest Wire · 7d ago20/20 Biologics reports second quarter 2026 financial results and recent operational progress, as cancer test revenue reaches record quarterly level
Quest Diagnostics Incorporated (NYSE: DGX) reported strong second quarter 2026 financial results, with revenue growth and earnings per share (EPS) exceeding expectations. The company posted second quarter revenues of $3.04 billion, a 10.2% increase compared to $2.76 billion in the same period of…
AInvest Wire · Aug 17, 2026Quest Diagnostics Inc: UBS raises target price to $232 from $220
AInvest Wire · Jul 24, 2026Quest Diagnostics shares up 10.9% after co forecasts annual revenue, profit above estimates
Quest Diagnostics (QDNGX) shares rose 10.9% in early trading on July 23, 2026, following the company’s announcement of stronger-than-expected financial guidance for the year. The diagnostic testing company projected annual revenue and profit that exceeded analyst estimates, signaling improved…
AInvest Wire · Jul 23, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.